X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (73) 73
neurology (65) 65
index medicus (60) 60
male (53) 53
neurosciences (51) 51
female (50) 50
alzheimer's disease (48) 48
aged (47) 47
dementia (37) 37
aged, 80 and over (32) 32
article (32) 32
atrophy (30) 30
mild cognitive impairment (30) 30
biomarkers (29) 29
magnetic resonance imaging (29) 29
clinical neurology (26) 26
middle aged (21) 21
mri (21) 21
psychiatry (21) 21
cognition (20) 20
neurologi (20) 20
neurovetenskaper (19) 19
brain (18) 18
cerebrospinal fluid (18) 18
alzheimers disease (17) 17
alzheimers-disease (17) 17
neuroimaging (17) 17
neuropsychological tests (17) 17
clinical medicine (16) 16
medical and health sciences (16) 16
medicin och hälsovetenskap (16) 16
memory (16) 16
abridged index medicus (15) 15
geriatrics & gerontology (15) 15
klinisk medicin (15) 15
amyloid beta-peptides - cerebrospinal fluid (14) 14
decline (14) 14
disease progression (14) 14
pathology (14) 14
tau (14) 14
alzheimer disease - pathology (13) 13
cerebrospinal-fluid (13) 13
cognitive ability (13) 13
impairment (13) 13
mental disorders (13) 13
alzheimer disease - cerebrospinal fluid (12) 12
apolipoproteins (12) 12
biomarkers - cerebrospinal fluid (12) 12
brain - pathology (12) 12
nervous system diseases (12) 12
positron-emission tomography (12) 12
alzheimer disease - diagnosis (11) 11
alzheimer’s disease (10) 10
cognitive dysfunction - pathology (10) 10
cohort studies (10) 10
internal medicine (10) 10
neurodegenerative diseases (10) 10
amyloid beta-peptides - metabolism (9) 9
animals (9) 9
brain - diagnostic imaging (9) 9
clinical trials (9) 9
deposition (9) 9
longitudinal studies (9) 9
medical imaging (9) 9
peptide fragments - cerebrospinal fluid (9) 9
risk factors (9) 9
studies (9) 9
tau protein (9) 9
beta-amyloid (8) 8
biomarker (8) 8
csf biomarkers (8) 8
geriatrics (8) 8
research article (8) 8
alzheimer disease (7) 7
alzheimer disease - psychology (7) 7
amyloid (7) 7
brain - metabolism (7) 7
brain atrophy (7) 7
cognition & reasoning (7) 7
depression (7) 7
disease (7) 7
genetic aspects (7) 7
gerontology (7) 7
hippocampus (7) 7
neurodegeneration (7) 7
neuroscience (7) 7
symptoms (7) 7
tau proteins - cerebrospinal fluid (7) 7
united states (7) 7
β-amyloid (7) 7
adni (6) 6
alzheimer disease - complications (6) 6
alzheimer disease - genetics (6) 6
analysis (6) 6
apoe (6) 6
association (6) 6
brain mapping (6) 6
cognition disorders - pathology (6) 6
cognitive decline (6) 6
cognitive dysfunction - cerebrospinal fluid (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 05/2010, Volume 303, Issue 19, pp. 1970 - 1971
Journal Article
Journal Article
Brain, ISSN 0006-8950, 2015, Volume 138, Issue 3, pp. 772 - 783
Journal Article
Aging & mental health, ISSN 1360-7863, 04/2019, pp. 1 - 4
To assess the relationships of somatic and anxiety symptoms of depression with functional disability in a sample of older adults with late life depression.... 
Journal Article
Neurology, ISSN 0028-3878, 10/2016, Volume 87, Issue 17, pp. 1827 - 1835
Journal Article
EMBO Molecular Medicine, ISSN 1757-4676, 10/2016, Volume 8, Issue 10, pp. 1184 - 1196
Journal Article
Psychiatric Services, ISSN 1075-2730, 11/2009, Volume 60, Issue 11, pp. 1466 - 1467
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2015, Volume 11, Issue 7, p. P35
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 04/2019, Volume 15, Issue 4, pp. 570 - 580
The relative importance of structural magnetic resonance imaging (MRI) and tau positron emission tomography (PET) to predict diagnosis and cognition in... 
Atrophy | Tau | MRI | Alzheimer | PET
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 04/2019, Volume 15, Issue 4, p. 570
The relative importance of structural magnetic resonance imaging (MRI) and tau positron emission tomography (PET) to predict diagnosis and cognition in... 
Neurosciences | PET imaging | Magnetic resonance imaging | Diagnosis | Alzheimer's disease
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 08/2019, Volume 9, Issue 1, pp. 11180 - 9
The independent effects of different brain pathologies on age-dependent cognitive decline are unclear. We examined this in 300 cognitively unimpaired elderly... 
INDIVIDUALS | AD DEMENTIA | BRAIN STRUCTURE | CORTICAL THICKNESS | MRI | CEREBROSPINAL-FLUID BIOMARKERS | ALZHEIMERS-DISEASE | DEPOSITION | MULTIDISCIPLINARY SCIENCES | TAU | DECLINE | Memory | Cortex | Cognitive ability | Inflammation | Cerebrospinal fluid | Atrophy | Magnetic resonance imaging | Tau protein | Neurodegeneration | β-Amyloid | Alzheimer's disease | Hippocampus | Age | Geriatrics
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 02/2019, Volume 15, Issue 2, p. 194
The aim was to create readily available algorithms that estimate the individual risk of [beta]-amyloid (A[beta]) positivity. The algorithms were tested in... 
Medical research | Neurosciences | Algorithms | Medicine, Experimental | Diagnostic imaging | Medical screening | Apolipoproteins | Alzheimer's disease
Journal Article
Neurology, ISSN 0028-3878, 02/2019, Volume 92, Issue 6, pp. e601 - e612
OBJECTIVETo examine the cross-sectional associations between regional tau, β-amyloid (Aβ), and cortical thickness and neuropsychological function across the... 
NATIONAL INSTITUTE | RECOMMENDATIONS | DIAGNOSTIC GUIDELINES | NEURODEGENERATION | AMYLOID BURDEN | PATHOLOGY | CEREBROSPINAL-FLUID | WORKGROUPS | PET | CLINICAL NEUROLOGY | IMPAIRMENT | 122 | 199 | 120
Journal Article
JAMA Neurology, ISSN 2168-6149, 05/2015, Volume 72, Issue 5, pp. 554 - 554
Alzheimer disease has a long preclinical stage characterized by beta -amyloid (A beta ) accumulation without symptoms. Several trials focus on this stage and... 
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 12/2016, Volume 48, p. 172
Cognitively-normal people with evidence of [beta]-amyloid (A[beta]) pathology and subtle cognitive dysfunction are believed to be at high risk for progression... 
Development and progression | Nervous system diseases | Cognition disorders | Alzheimer's disease | Analysis
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.